Celularity Inc. – NASDAQ:CELUW

Celularity stock price today

$0.06
+0.04
+296.03%
Financial Health
0
1
2
3
4
5
6
7
8
9

Celularity stock price monthly change

-16.20%
month

Celularity stock price quarterly change

-16.20%
quarter

Celularity stock price yearly change

-67.32%
year

Celularity key metrics

Market Cap
47.84M
Enterprise value
34.51M
P/E
-0.08
EV/Sales
1.84
EV/EBITDA
-9.21
Price/Sales
0.53
Price/Book
0.06
PEG ratio
N/A
EPS
-10.18
Revenue
14.78M
EBITDA
-120.27M
Income
-181.40M
Revenue Q/Q
-8.44%
Revenue Y/Y
-20.93%
Profit margin
-76.37%
Oper. margin
-310.32%
Gross margin
-2.01%
EBIT margin
-310.32%
EBITDA margin
-813.35%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Celularity stock price history

Celularity stock forecast

Celularity financial statements

Celularity Inc. (NASDAQ:CELUW): Profit margin
Dec 2022 4.12M 24.43M 591.77%
Mar 2023 3.93M -64.01M -1626.86%
Jun 2023 2.93M -47.94M -1632.03%
Sep 2023 3.78M -93.87M -2479.56%
Celularity Inc. (NASDAQ:CELUW): Debt to assets
Dec 2022 401066000 202.16M 50.41%
Mar 2023 362416000 206.78M 57.06%
Jun 2023 246419000 127.91M 51.91%
Sep 2023 157192000 126.94M 80.76%
Celularity Inc. (NASDAQ:CELUW): Cash Flow
Dec 2022 -29.58M -779K 1.68M
Mar 2023 -14.99M -3.20M 12.75M
Jun 2023 -11.02M -31K 5.61M
Sep 2023 -8.32M -228K 5.73M

Celularity alternative data

Celularity Inc. (NASDAQ:CELUW): Employee count
Aug 2023 225
Sep 2023 225
Oct 2023 225
Nov 2023 225
Dec 2023 225
Jan 2024 225
Feb 2024 225
Mar 2024 225
Apr 2024 225
May 2024 225
Jun 2024 225
Jul 2024 225

Celularity other data

1.48% -3.38%
of CELUW is owned by hedge funds
2.21M -5.10M
shares is hold by hedge funds

Celularity Inc. (NASDAQ:CELUW): Insider trades (number of shares)
Period Buy Sel
Nov 2022 90000 0
Transaction Date Insider Security Shares Price per share Total value Source
Option
DIAMANDIS PETER director
Stock Option (Right to Buy) 1,071,000 $0.28 $299,880
Option
DIAMANDIS PETER director
Class A Common Stock 1,071,000 $0.28 $299,880
Purchase
HARIRI ROBERT J director, officer: Chief Execut..
Class A Common Stock 10,000 $1.72 $17,180
Purchase
HARIRI ROBERT J director, officer: Chief Execut..
Class A Common Stock 40,000 $1.71 $68,400
Purchase
HARIRI ROBERT J director, officer: Chief Execut..
Class A Common Stock 40,000 $1.74 $69,600
Option
SCULLEY JOHN director
Stock Option (Right to Buy) 768,594 $0.28 $215,206
Option
SCULLEY JOHN director
Class A Common Stock 768,594 $0.28 $215,206
Option
HARIRI ROBERT J director, officer: Chief Execut..
Stock Option (Right to Buy) 119,073 $2.87 $341,740
Option
HARIRI ROBERT J director, officer: Chief Execut..
Class A Common Stock 119,073 $2.87 $341,740
Option
VON ESCHENBACH ANDREW C. director
Stock Option (Right to Buy) 100,000 $0.28 $28,000
  • What's the price of Celularity stock today?

    One share of Celularity stock can currently be purchased for approximately $0.06.

  • When is Celularity's next earnings date?

    Unfortunately, Celularity's (CELUW) next earnings date is currently unknown.

  • Does Celularity pay dividends?

    No, Celularity does not pay dividends.

  • How much money does Celularity make?

    Celularity has a market capitalization of 47.84M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 26.68% to 22.77M US dollars.

  • What is Celularity's stock symbol?

    Celularity Inc. is traded on the NASDAQ under the ticker symbol "CELUW".

  • What is Celularity's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Celularity?

    Shares of Celularity can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Celularity have?

    As Jul 2024, Celularity employs 225 workers.

  • When Celularity went public?

    Celularity Inc. is publicly traded company for more then 4 years since IPO on 19 Jul 2021.

  • What is Celularity's official website?

    The official website for Celularity is celularity.com.

  • Where are Celularity's headquarters?

    Celularity is headquartered at 170 Park Avenue, Florham Park, NJ.

  • How can i contact Celularity?

    Celularity's mailing address is 170 Park Avenue, Florham Park, NJ and company can be reached via phone at +90 87682170.

Celularity company profile:

Celularity Inc.

celularity.com
Exchange:

NASDAQ

Full time employees:

120

Industry:

Biotechnology

Sector:

Healthcare

Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-derived CAR-T therapy, which is in Phase I clinical trial for the treatment of B-cell malignancies; CYNK-001, placental-derived unmodified natural killer (NK) cell that is in Phase I clinical trial to treat acute myeloid leukemia, as well as in Phase I/IIa clinical trial for the treatment of glioblastoma multiforme and COVID-19; CYNK-101, an allogeneic genetically modified NK cell, which is in Phase I clinical trial to treat HER2+ gastric and gastroesophageal cancers; APPL-001, a placenta-derived mesenchymal-like adherent stromal cell that is in a pre-clinical stage for the treatment of Crohn's disease; and PDA-002, a placenta-derived mesenchymal-like adherent stromal cell, which is in pre-clinical stage for the treatment of facioscapulohumeral muscular dystrophy. It also sells and licenses products that are used in surgical and wound care markets, such as Biovance and Interfyl; collects stem cells from umbilical cords and placentas; and provides cells storage under the LifebankUSA brand. The company was incorporated in 2016 and is headquartered in Florham Park, New Jersey.

170 Park Avenue
Florham Park, NJ 07932

CIK: 0001752828
ISIN: US1511901134
CUSIP: 151190113